● Recruiting

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Condition: Parenteral Nutrition Associated Liver Disease (PNALD) · Essential Fatty Acid Deficiency · Malnutrition · Sponsor: Fresenius Kabi

PhaseN/A

Planned participants40

Who can joinAll sexes, 1 Day to 17 Years

Healthy volunteersNo

About this study

This study will demonstrate safety in pediatric patients with Parenteral Nutrition-Associated Cholestasis treated with Omegaven®, which is indicated as a source of calories and fatty acids in this patient population

This description comes directly from the study's public registry record.

Talk to the study team

Niess Ulf, PhD · M +49 173 5439924 · ulf.niess@fresenius-kabi.com

Lohse Jean-Marc, PhD · +49 173 5420453 · Jean-Marc.Lohse@fresenius-kabi.com

Always discuss trial participation with your own doctor first.

Locations (10)

Memorial Health Service	Fountain Valley, California, United States	Recruiting
University of California Los Angeles	Los Angeles, California, United States	Recruiting
The University of Chicago	Chicago, Illinois, United States	Recruiting
Children's Hospital Corporation d/b/a Boston Children's Hospital	Boston, Massachusetts, United States	Recruiting
Children's Hospital Medical Center	Cincinnati, Ohio, United States	Recruiting
Board of Regents of the University of Oklahoma Health Sciences Center	Oklahoma City, Oklahoma, United States	Recruiting
Vanderbilt University Medical Center	Nashville, Tennessee, United States	Recruiting
Baylor College of Medicine Houston	Houston, Texas, United States	Recruiting
The University of Texas Health Science Center at San Antonio	San Antonio, Texas, United States	Recruiting
Seattle Children's Hospital d/b/a Seattle Children's Research Institute	Seattle, Washington, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06274788